Angion Announces Several Strategic Additions to its Management Team to Support the Future Development and Commercialization of ANG-3777

NEXT STORY
REMINDER – Tesamorelin Study Results on NAFLD Published in Lancet HIV
PREV STORY
Innovation Pharmaceuticals Partnering Provides Momentum For Inflammatory Bowel Disease Programs, Targeting a Substantial and Prized Market with a Large Unmet Patient Need
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Replimune Appoints Tanya Lewis as Chief Development Operations Officer

author_avatar
NASDAQ Market News

ContraFect Presents Additional Positive Data from the Phase 2 Trial of Exebacase at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

author_avatar
NASDAQ Market News

The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6%

author_avatar
NASDAQ Market News